Canada markets open in 8 hours 34 minutes

Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
Add to watchlist
7.52-0.07 (-0.92%)
As of 12:41PM CST. Market open.
Currency in CNY

Valuation Measures4

Market Cap (intraday) 50.44B
Enterprise Value 45.51B
Trailing P/E 27.40
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.27
Price/Book (mrq)1.66
Enterprise Value/Revenue 5.72
Enterprise Value/EBITDA 20.08

Trading Information

Stock Price History

Beta (5Y Monthly) 0.37
52-Week Change 32.02%
S&P500 52-Week Change 324.96%
52 Week High 38.68
52 Week Low 35.93
50-Day Moving Average 37.26
200-Day Moving Average 37.23

Share Statistics

Avg Vol (3 month) 334.94M
Avg Vol (10 day) 345.21M
Shares Outstanding 56.65B
Implied Shares Outstanding 66.65B
Float 84.41B
% Held by Insiders 130.49%
% Held by Institutions 127.07%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.03
Forward Annual Dividend Yield 40.40%
Trailing Annual Dividend Rate 30.03
Trailing Annual Dividend Yield 30.40%
5 Year Average Dividend Yield 4N/A
Payout Ratio 410.83%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 05, 2024
Last Split Factor 218:10
Last Split Date 3Sept 28, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 22.84%
Operating Margin (ttm)28.60%

Management Effectiveness

Return on Assets (ttm)4.36%
Return on Equity (ttm)6.07%

Income Statement

Revenue (ttm)7.96B
Revenue Per Share (ttm)1.19
Quarterly Revenue Growth (yoy)-0.30%
Gross Profit (ttm)N/A
EBITDA 2.38B
Net Income Avi to Common (ttm)1.82B
Diluted EPS (ttm)0.28
Quarterly Earnings Growth (yoy)5.30%

Balance Sheet

Total Cash (mrq)4.93B
Total Cash Per Share (mrq)0.74
Total Debt (mrq)2.03M
Total Debt/Equity (mrq)0.01%
Current Ratio (mrq)4.05
Book Value Per Share (mrq)4.59

Cash Flow Statement

Operating Cash Flow (ttm)1.96B
Levered Free Cash Flow (ttm)1.23B